Interestingly, it has been shown that the novel Wip1 inhibitor GSK2830371 reduced the growth of neuroblastoma xenografts in mice and enhanced the cytotoxicity caused by topoisomerase II inhibitors [61]. The gene discussed is PPM1D; the disease is neuroblastoma.